NIMY Resources has reported record-high gallium grades at its Block 3 East prospect, positioning itself as a potential key supplier in a market set to surge tenfold by 2034.
Imricor Medical Systems reports strong Q4 CY24 progress with successful FDA review, CE Mark submissions, and an 840% jump in consumables revenue, positioning the company for expanded global market penetration.
FleetPartners Group Limited reported a robust 13% increase in adjusted EPS for FY24, propelled by targeted market growth, operational transformation, and a disciplined share buy-back program. The company remains optimistic about sustaining momentum despite a modest dip in new business writings in early FY25.
Bubs Australia has reported a strong Q2 FY25 performance with a positive EBITDA turnaround and robust revenue growth, while advancing its critical FDA clinical trial in the US.
Montaka Global Long Only Equities Fund has announced a distribution of 11.30 cents per unit for the half-year ending 31 December 2024, continuing its commitment to delivering steady income alongside capital growth.